Piramal Bags Coldstream For Edge In Antibody-Drug Conjugates
This article was originally published in PharmAsia News
Executive Summary
Piramal has acquired Coldstream of the U.S. in a move that helps the Indian company engage with cutting edge biotech drug makers and offer full spectrum services through proprietary capabilities in antibody-drug conjugates (ADCs).